CIK 0001752828
- Emerging growth company
Celularity Inc
Sign in to watch- Ticker
- CELU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831702591
- Phone
- +1 908-768-2170
- Business address
- 170 PARK AVE, FLORHAM PARK, NJ, 07932
- Former names
- GX Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-14 | SCULLEY JOHN Director | Grant or award | +199,921 | 1,004,660 | ||
| 2023-06-14 | SCULLEY JOHN Director | Grant or award · Stock Option (Right to Buy) | +277,778 | 277,778 | ||
| 2022-08-26 | SCULLEY JOHN Director | Exercise or conversion | +768,594 | $0.28 | $215K | 804,739 |
| 2022-08-26 | SCULLEY JOHN Director | Exercise or conversion · Stock Option (Right to Buy) | −768,594 | 0 | ||
| 2022-07-13 | SCULLEY JOHN Director | Grant or award | +36,145 | 36,145 | ||
| 2022-07-13 | SCULLEY JOHN Director | Grant or award · Stock Option (Right to Buy) | +54,152 | 54,152 | ||
| 2021-09-09 | SCULLEY JOHN Director | Grant or award · Stock Option (Right to Buy) | +56,053 | 56,053 | ||
| 2021-07-16 | SCULLEY JOHN Director | Grant or award · Stock Option (Right to Buy) | +768,594 | 768,594 | ||
| 2021-07-16 | SCULLEY JOHN Director | Grant or award · Deferred Compensation Award (Right to Buy) | +269,007 | 269,007 |
Page 1 of 1 · 9 trades